CHU Sainte-Justine Research Center

CHU Sainte-Justine Research Center
Name	CHU Sainte-Justine Research Center
Established	1973
Location	Montreal, Quebec, Canada
Type	Pediatric research institute
Director	Dr. (position)
Affiliated	Université de Montréal, Sainte-Justine University Hospital Centre

Contents

CHU Sainte-Justine Research Center CHU Sainte-Justine Research Center is a pediatric biomedical research institute affiliated with Université de Montréal and located in Montreal. The center contributes to clinical care at the adjacent Sainte-Justine University Hospital Centre and participates in provincial networks such as Institut national de santé publique du Québec and national initiatives including Canadian Institutes of Health Research. It maintains partnerships with international organizations like World Health Organization and collaborates with academic institutions including McGill University, Harvard University, and University of Toronto.

History

The research center traces origins to the founding of Sainte-Justine hospital in 1907 and the expansion of research activities during the 20th century alongside institutions like Laval University and McMaster University. In the 1970s the center formalized research governance amid contemporaneous developments at Institut de recherche en santé publique de Montréal and initiatives by Canadian Institutes of Health Research. Major milestones include integration with pediatric networks such as Canadian Pediatric Society and participation in multicenter studies associated with Children's Hospital of Philadelphia and Great Ormond Street Hospital. The center's growth paralleled federal and provincial policy shifts exemplified by programs from Health Canada and collaborations with foundations like SickKids Foundation and March of Dimes.

The center operates within a governance framework involving academic leadership from Université de Montréal, clinical leadership from Sainte-Justine University Hospital Centre, and advisory input from bodies similar to Canadian Foundation for Innovation and Network of Centers of Excellence. Executive oversight engages stakeholders drawn from institutions such as Fondation CHU Sainte-Justine, private partners akin to Pfizer, and provincial health authorities comparable to Ministère de la Santé et des Services sociaux (Québec). Research ethics and compliance align with guidelines produced by entities like Tri-Council Policy Statement and boards modeled on Institutional Review Board structures found at Johns Hopkins University and Stanford University.

Research programs encompass domains including pediatric oncology paralleling work at Dana-Farber Cancer Institute, neonatology with methodologies used by March of Dimes Research Center, genetics comparable to Broad Institute, and immunology resonant with Institut Pasteur. Specialized centers address perinatal epidemiology in collaboration with Public Health Agency of Canada, metabolic disorders analogous to research at Mount Sinai Hospital (Toronto), and rare diseases linked to consortia such as Orphanet. Interdisciplinary initiatives include bioinformatics groups collaborating with European Bioinformatics Institute, imaging cores employing technologies from Siemens Healthineers, and biobanks following standards from International Society for Biological and Environmental Repositories.

The center conducts phase I–III trials in pediatrics with regulatory frameworks similar to those of Health Canada and the Food and Drug Administration. Trials have involved partnerships with pharmaceutical companies like Roche, biotechnology firms akin to Moderna, and academic trial networks such as Canadian Cancer Trials Group. Translational activities move findings into practice in collaboration with clinical partners including Montreal Children's Hospital and policy organizations like Institut national d'excellence en santé et en services sociaux. Multicenter studies often include sites such as University Health Network and St. Michael's Hospital and participate in international consortia coordinated with European Medicines Agency-aligned investigators.

The center hosts trainees from Université de Montréal, postdoctoral fellows from programs modeled after Marie Skłodowska-Curie Actions, and medical residents linked to Royal College of Physicians and Surgeons of Canada. It collaborates on curriculum development with universities like McGill University and participates in exchange programs with institutions such as Université Laval, Imperial College London, and University of California, San Francisco. Partnerships extend to nonprofit organizations including Canadian Cancer Society and international groups like UNICEF for child health initiatives.

Laboratories are equipped for genomics using platforms from companies like Illumina and proteomics comparable to Thermo Fisher Scientific. Core facilities include imaging suites with modalities similar to those at Montreal Neurological Institute, neonatal intensive care study units modeled on Ottawa Hospital Research Institute, and GMP-compliant biomanufacturing spaces reflecting standards used by National Research Council (Canada). Data management and secure computing infrastructure align with practices at Compute Canada and involve collaborations with cloud providers used by institutions such as University of Toronto.

Funding sources combine competitive grants from Canadian Institutes of Health Research, infrastructure awards from Canada Foundation for Innovation, philanthropic donations via Fondation CHU Sainte-Justine, and industry contracts with companies like Sanofi and GlaxoSmithKline. The center's outputs have influenced clinical guidelines promulgated by organizations such as Canadian Paediatric Society and contributed to international literature alongside work from World Health Organization-affiliated researchers. Its translational contributions inform policy deliberations in forums involving Health Canada, provincial ministries like Ministère de la Santé et des Services sociaux (Québec), and global child health stakeholders including UNICEF.